arrow
Back
C

Cristina Saura

Vall d'Hebron Institute of Oncology

61H-index
739Paper Count
1.9WCitation Count
Published Papers 216
Publication Date
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial
err2026-05-28
err0
PREAI
errOlivia Pagani; Samuel M. Niman; Monica Ruggeri; Fedro A. Peccatori; Hatem A. Azim; Marco Colleoni; Cristina Saura; Chikako Shimizu; Anna Barbro Sætersdal; Judith R. Kroep; Ellen Warner; Frédéric Amant; Audrey Mailliez; Halle C.F. Moore; Manuel Ruiz-Borrego; Janice M. Walshe; Virginia F. Borges; Andrea Gombos; Akemi Kataoka; Christine Rousset-Jablonski
errShare
errSave
Quality and safety of research biopsies in oncology clinical trials.
err2026-05-25
err0
errOAAI
errPaolo Nuciforo; Fiorella Ruiz-Pace; José Jimenez; Raquel Comas; Roberta Fasani; Cristina Viaplana; Cesar Sevillano; Paola Martinez; Xavier Serres-Créixams; Nuria Roson; Cristina Saura; Elena Elez; Ana Oaknin; Irene Braña Garcia; Eva Muñoz-Couselo; Teresa Macarulla Mercade; Joan Carles; Josep Tabernero; Enriqueta Felip; Elena Garralda
errShare
errSave
Analysis of UGT1A1 germline variants in patients with advanced breast cancer treated with trastuzumab-deruxtecan: results from the PROCURE Project
err2026-05-11
err0
errOAAI
errR. Sánchez-Bayona; J. de Nicolás-Hernández; C. Saura; M. Gion; J.M. Cejalvo; E. Llabrés; J. Cortés; A. Falcón; S. Pernas; A. López de Sa; M. Vidal; C. Hinojo; T. Curiel; J. Cruz; V. Martínez; B. Cantos; M.J. Echarri; I. Gallegos; C. Bueno; A.M. Vargas
errShare
errSave
Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trial
err2026-04-27
err0
errOAAI
errJoyce O’Shaughnessy; Francois-Clement Bidard; Patrick Neven; Monica Lis Casalnuovo; Philippe Aftimos; Cristina Saura; Nadia Harbeck; Lisa A. Carey; Giuseppe Curigliano; Jose A. Garcia-Saenz; Maria Fernandez Abad; Larissa de Paula; Yeon Hee Park; Ozgur Ozyilkan; Maria Munoz; Emily Barrett; Shanshan Cao; Aarti Chawla; Komal L. Jhaveri
errShare
errSave
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer: Updated Efficacy Results from the phase 3 EMBER-3 trial
err2025-12-12
err0
errOAAI
errK.L. Jhaveri; P. Neven; M.L. Casalnuovo; S-B. Kim; E. Tokunaga; P. Aftimos; C. Saura; J. O’Shaughnessy; N. Harbeck; L.A. Carey; G. Curigliano; J. Watanabe; E. Lim; J. Huang; Z. Qingyuan; A. Llombart-Cussac; C. Huang; B. Desai; Y. Limay; X.A. Wang
errShare
errSave
Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysis
err2025-12-03
err0
PREAI
errAlicia Escudero; Meritxell Bellet; Cristina Saura; Anna Aguilera; Andri Papakonstantinou; Pablo Tolosa; José Ángel García-Sáenz; Fernando Moreno; Alfonso López de Sá; Francesco Schettini; Elia Seguí; Marta Gonzalez-Rodriguez; Victor Navarro; Juan Manuel Ferrero-Cafiero; Xavier González; Cristina Hernando; Alexios Matikas; Aleix Prat; Mafalda Oliveira; Tomas Pascual
errShare
errSave
Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03
err2025-11-18
err0
PREAI
errC. Saura; J. Cortés; S. Modi; S.-B. Kim; E. Hamilton; S.A. Hurvitz; I.E. Krop; G. Curigliano; H. Iwata; S.-A. Im; P. Herbolsheimer; M. Karnoub; A. Boran; Y. Kuwahara; A. Egorov; F. André
errShare
errSave
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02
err2025-11-17
err0
errOAAI
errS.A. Hurvitz; S. Loi; J. O’Shaughnessy; A.F.C. Okines; S.M. Tolaney; J. Sohn; C. Saura; X. Zhu; D. Cameron; T. Bachelot; E. Hamilton; G. Curigliano; A.C. Wolff; N. Harbeck; N. Masuda; L. Vahdat; K. Zaman; F. Valdes-Albini; M. Block; T. Pluard
errShare
errSave
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors
err2025-11-06
err0
errOAAI
errR. Dienstmann; A. Vivancos; P. Nuciforo; S. Aguilar; F. Ruiz-Pace; C. Viaplana; J. Gonzalez; B. Fite; A. Pedrola; E. Elez; C. Saura; E. Felip; T. Macarulla; J. Capdevila; L. Fariñas-Madrid; J. Carles; J. Mateo; E. Muñoz-Cosuelo; J. Balmaña; I. Braña; E. Garralda; J. Tabernero
errShare
errSave
European experience of patients with HER2-positive advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: the EUROPA T-DXd study
err2025-10-14
err0
errOAAI
errCristina Saura; Hans Wildiers; Giampaolo Bianchini; José Ángel García-Saenz; Arthur Allignol; Amanda Logue; Markus Lucerna; Sabine Stamenitis; Michelino De Laurentiis
errShare
errSave
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial
err2025-10-01
err0
PREAI
errLoi, Sherene; Salgado, Roberto; Curigliano, Giuseppe; Ivan Romero Diaz, Roberto; Delaloge, Suzette; Rojas Garcia, Carlos Ignacio; Kok, Marleen; Saura, Cristina; Harbeck, Nadia; Mittendorf, Elizabeth A.; Yardley, Denise A.; Suarez Zaizar, Alberto; Caminos, Facundo Rufino; Ungureanu, Andrei; Reinoso-Toledo, Joaquin G.; Guarneri, Valentina; Egle, Daniel; Ades, Felipe; Pacius, Misena; Chhibber, Aparna; Chandra, Rajalakshmi; Nathani, Raheel; Spires, Thomas; Qun Wu, Jenny; Pusztai, Lajos; Mcarthur, Heather
errShare
errSave
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial
err2025-09-30
err0
errOAAI
errE. Seguí; F. Brasó-Maristany; T. Pascual; E. Sanfeliu; I. Victoria; C. Saura; C. Hierro; A. López-González; Y. Izarzugaza; E. Ciruelos; J. Gavilá; F. Racca; J.M. Cejalvo; K. Amillano; L. Paz-Ares; M. Juan; E. Felip; E. Garralda; B. González; A. Arance; J. Martín-Liberal; B. Conte; B. Walbaum; A. Indacochea; O. Castillo; P. Blasco; F. Pardo; Á. Aguirre; V. Sirenko; X. González; P. Galván; A. Vivancos; J.M. Ferrero-Cafiero; A. Mulero-Sánchez; F. Salvador; G. Villacampa; R. Mesía; A. Cervantes; A. Prat; J. Tabernero
errShare
errSave
Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]
err2025-09-22
err0
PREAI
errIsabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori
errShare
errSave
Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers
err2025-08-13
err0
errOAAI
errM. Perachino; E. Blondeaux; V. Delucchi; R. Bernstein Molho; S. Frank; S. Paluch-Shimon; S. Linn; A. Di Meglio; F. Peccatori; H.C.F. Moore; A. Parokonnaya; T. Renaud; K.A. Rodriguez Wallberg; A.H. Partridge; K. Pogoda; A. Ferrari; H. Wildiers; A. Toss; C. Rousset-Jablonski; H.J. Kim; M. Varela; O. Cordoba; C. Tanase Damian; M. Marhold; A. Fabi; S.L. Graff; A. Rodriguez-Hernandez; M. Okano; R. Duchnowska; H. Luna Pais; R. Di Rocco; H.A. Azim; E. Mariamidze; H.R. Kourie; L. Arecco; E. Carrasco; E. Agostinetto; J. Balmana; C. Saura; M. Lambertini
errShare
errSave
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial
err2025-07-26
err0
errOAAI
errIsabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori
errShare
errSave
Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374)
err2025-07-01
err0
PREAI
errV. Gambardella; M.K. Accordino; P.L. Bedard; A. Cervantes; E. Hamilton; A. Italiano; K. Kalinsky; I.E. Krop; M. Oliveira; C. Saura; P. Schmid; N.C. Turner; A. Varga; A. Fernandez-Saranillo; Y. Jin; S. Royer-Joo; U. Peters; N. Shankar; J.L. Schutzman; D. Juric; K.L. Jhaveri
errShare
errSave
Identifying germline pathogenic variants in breast cancer using tumor sequencing
errBREAST
IF7.9
err2025-06-01
err0
errOAAI
errCruellas, Mara; Papakonstantinou, Andri; Lopez-Fernandez, Adria; Castillo, Ester; Matito, Judit; Gomez, Marina; Rezqallah, Alejandra; Vega, Sharela; Navarro, Victor; Torres, Maite; Moles-Fernandez, Alejandro; Saura, Cristina; Vivancos, Ana; Balmana, Judith; Oliveira, Mafalda
errShare
errSave
Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study
err2025-05-05
err0
PREAI
errSantiago Escrivá-de-Romani; Juan M Cejalvo; Emilio Alba; Jennifer Friedmann; Álvaro Rodríguez-Lescure; Marie-France Savard; Rossanna C Pezo; Maria Gion; Manuel Ruiz-Borrego; Erika Hamilton; Timothy Pluard; Marc Webster; Muralidhar Beeram; Hannah Linden; Cristina Saura; Diana Shpektor; Bob Salim; Phoebe Harvey; Sara A Hurvitz
errShare
errSave
Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis
err2025-02-13
err0
errOAAI
errPerachino, Marta; Blondeaux, Eva; Molinelli, Chiara; Ruelle, Tommaso; Giannubilo, Irene; Arecco, Luca; Nardin, Simone; Razeti, Maria Grazia; Borea, Roberto; Favero, Diletta; Lanzavecchia, Chiara; Chiappe, Edoardo; Tomasello, Loredana; Mariamidze, Elene; Jankovic, Kristina; Stana, Mihaela; Ottonello, Silvia; Scavone, Graziana; de Moura Leite, Luciana; Spinaci, Stefano; Saura, Cristina; Lambertini, Matteo
errShare
errSave
Expert HER2-positive Volkmar Julia Emilie a The University b Centre c Department
err2025-01-01
err0
errOAAI
errMueller, Volkmar; Bachelot, Thomas; Curigliano, Giuseppe; de Azambuja, Evandro; Furtner, Julia; Gempt, Jens; Jereczek-Fossa, Barbara Alicja; Jerzak, Katarzyna J.; Le Rhun, Emilie; Palmieri, Carlo; Pravettoni, Gabriella; Saura, Cristina; Bartsch, Rupert
errShare
errSave